home / stock / bysi / bysi quote
Last: | $2.44 |
---|---|
Change Percent: | 1.97% |
Open: | $2.49 |
Close: | $2.44 |
High: | $2.5999 |
Low: | $2.4101 |
Volume: | 17,046 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.44 | $2.49 | $2.44 | $2.5999 | $2.4101 | 17,046 | 05-08-2024 |
$2.54 | $2.28 | $2.54 | $2.67 | $2.26 | 95,975 | 05-07-2024 |
$2.28 | $2.25 | $2.28 | $2.3971 | $2.23 | 18,776 | 05-06-2024 |
$2.25 | $2.18 | $2.25 | $2.32 | $2.18 | 45,518 | 05-03-2024 |
$2.1601 | $2.12 | $2.1601 | $2.2498 | $2.0601 | 33,779 | 05-02-2024 |
$2.06 | $2.01 | $2.06 | $2.1 | $1.7343 | 29,456 | 05-01-2024 |
$2.01 | $2.2 | $2.01 | $2.2 | $2.0015 | 13,285 | 04-30-2024 |
$2.22 | $2.14 | $2.22 | $2.29 | $2.1398 | 10,122 | 04-29-2024 |
$2.13 | $2.36 | $2.13 | $2.38 | $2.1 | 33,805 | 04-26-2024 |
$2.27 | $2.4 | $2.27 | $2.4076 | $2.26 | 28,389 | 04-25-2024 |
$2.43 | $2.29 | $2.43 | $2.5 | $2.24 | 97,152 | 04-24-2024 |
$2.29 | $2.18 | $2.29 | $2.379 | $2.175 | 112,151 | 04-23-2024 |
$2.11 | $1.92 | $2.11 | $2.24 | $1.92 | 63,530 | 04-22-2024 |
$1.91 | $1.8 | $1.91 | $1.968 | $1.8 | 80,217 | 04-19-2024 |
$1.8 | $1.84 | $1.8 | $1.84 | $1.8 | 55,502 | 04-18-2024 |
$1.85 | $1.8 | $1.85 | $1.98 | $1.79 | 104,609 | 04-17-2024 |
$1.8 | $1.77 | $1.8 | $1.8937 | $1.77 | 37,542 | 04-16-2024 |
$1.76 | $2.03 | $1.76 | $2.0702 | $1.76 | 75,265 | 04-15-2024 |
$2.09 | $2.04 | $2.09 | $2.27 | $2.04 | 46,767 | 04-12-2024 |
$2.06 | $2.23 | $2.06 | $2.3 | $1.9 | 130,211 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
BeyondSpring Inc. Company Name:
BYSI Stock Symbol:
NASDAQ Market:
FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) ("BeyondSpring" or the "Company"), a clinical-stage global ...
FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced it will host a Research...
FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it has filed its...